Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Woltsche, N; Schwab, C; Deinlein, T; Hofmann-Wellenhof, R; Zalaudek, I.
Dermoscopy in the era of dermato-oncology: from bed to bench side and retour.
Expert Rev Anticancer Ther. 2016; 16(5):531-541
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Deinlein Teresa Maria
Hofmann-Wellenhof Rainer
Schwab Christoph
Woltsche Nora
Zalaudek Iris
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
Today dermoscopy is standard-of-care in the diagnosis and management of patients with benign and malignant skin tumors because it increases the diagnostic accuracy of skin lesions compared to the naked-eye examination up to 25%. Despite its role in the routine dermato-oncology, it increasingly gained interest as a bridge connecting clinical with basic molecular research in dermato-oncology. Here, we correlate dermoscopy patterns of nevi and melanomas with high and low susceptibility genes and somatic mutations, provide an overview on the clinical and dermoscopic patterns of cutaneous melanoma subtypes, and highlight the role of dermoscopy in the diagnosis of skin eruptions during systemic treatments of advanced melanoma including targeted therapies and immunotherapies.
Find related publications in this database (using NLM MeSH Indexing)
Dermoscopy - methods
Genetic Predisposition to Disease -
Humans -
Immunotherapy - adverse effects
Immunotherapy - methods
Melanoma - diagnosis
Melanoma - genetics
Melanoma - pathology
Molecular Targeted Therapy - adverse effects
Molecular Targeted Therapy - methods
Mutation -
Nevus - diagnosis
Nevus - genetics
Nevus - pathology
Reproducibility of Results -
Skin Diseases - diagnosis
Skin Diseases - genetics
Skin Diseases - pathology
Skin Neoplasms - diagnosis
Skin Neoplasms - genetics
Skin Neoplasms - pathology

Find related publications in this database (Keywords)
Dermoscopy
nevi
melanoma
genetics
targeted therapy
immune checkpoint inhibitors
© Meduni Graz Impressum